| Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation NA Menzies, T Cohen, HH Lin, M Murray, JA Salomon PLoS Med 9 (11), e1001347, 2012 | 234 | 2012 |
| The costs and effectiveness of four HIV counseling and testing strategies in Uganda N Menzies, B Abang, R Wanyenze, F Nuwaha, B Mugisha, A Coutinho, ... Aids 23 (3), 395-401, 2009 | 220 | 2009 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 207 | 2014 |
| The cost of providing comprehensive HIV treatment in PEPFAR-supported programs NA Menzies, AA Berruti, R Berzon, S Filler, R Ferris, TV Ellerbrock, ... AIDS (London, England) 25 (14), 1753, 2011 | 144 | 2011 |
| Increasing access to HIV counseling and testing through mobile services in Kenya: Strategies, utilization and cost-effectiveness KL Grabbe, N Menzies, M Taegtmeyer, G Emukule, P Angala, I Mwega, ... Journal of acquired immune deficiency syndromes (1999) 54 (3), 317, 2010 | 130 | 2010 |
| Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ... The Lancet Global Health 4 (11), e806-e815, 2016 | 114 | 2016 |
| The determinants of HIV treatment costs in resource limited settings NA Menzies, AA Berruti, JM Blandford PloS one 7 (11), e48726, 2012 | 64 | 2012 |
| Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models D Keebler, P Revill, S Braithwaite, A Phillips, N Blaser, A Borquez, ... The Lancet Global Health 2 (1), e35-e43, 2014 | 63 | 2014 |
| Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models NA Menzies, GB Gomez, F Bozzani, S Chatterjee, N Foster, IG Baena, ... The Lancet Global Health 4 (11), e816-e826, 2016 | 59 | 2016 |
| Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions NA Menzies, E Wolf, D Connors, M Bellerose, AN Sbarra, T Cohen, ... The Lancet Infectious Diseases 18 (8), e228-e238, 2018 | 49 | 2018 |
| The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models C Pretorius, NA Menzies, L Chindelevitch, T Cohen, A Cori, JW Eaton, ... Aids 28, S25-S34, 2014 | 43 | 2014 |
| Nowcasting by Bayesian Smoothing: A flexible, generalizable model for real-time epidemic tracking SF McGough, MA Johansson, M Lipsitch, NA Menzies PLoS computational biology 16 (4), e1007735, 2020 | 37 | 2020 |
| Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model NA Menzies, T Cohen, AN Hill, R Yaesoubi, K Galer, E Wolf, SM Marks, ... American journal of epidemiology 187 (9), 2011-2020, 2018 | 37 | 2018 |
| Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study S Verguet, C Riumallo-Herl, GB Gomez, NA Menzies, RMGJ Houben, ... The Lancet Global Health 5 (11), e1123-e1132, 2017 | 36 | 2017 |
| Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings NA Menzies, J Homsy, JYC Pitter, C Pitter, J Mermin, R Downing, ... The Pediatric infectious disease journal 28 (9), 819-825, 2009 | 33 | 2009 |
| Bayesian methods for calibrating health policy models: a tutorial NA Menzies, DI Soeteman, A Pandya, JJ Kim Pharmacoeconomics 35 (6), 613-624, 2017 | 32 | 2017 |
| An efficient estimator for the expected value of sample information NA Menzies Medical Decision Making 36 (3), 308-320, 2016 | 26 | 2016 |
| Characteristics of HIV care and treatment in PEPFAR-supported sites S Filler, AA Berruti, N Menzies, R Berzon, TV Ellerbrock, R Ferris, ... Journal of acquired immune deficiency syndromes (1999) 57 (1), e1, 2011 | 26 | 2011 |
| Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study FM Marx, R Yaesoubi, NA Menzies, JA Salomon, A Bilinski, N Beyers, ... The Lancet Global Health 6 (4), e426-e435, 2018 | 24 | 2018 |
| The importance of heterogeneity to the epidemiology of tuberculosis JM Trauer, PJ Dodd, MGM Gomes, GB Gomez, RMGJ Houben, ... Clinical infectious diseases 69 (1), 159-166, 2019 | 23 | 2019 |
